Laekna, Inc. (2105) Price & Analysis

Compare

3 Followers

2105 Stock Chart & Stats

HK$16.73

-HK$0.72(-6.22%)

At close: Jan 08 4:00 PM EST

HK$16.73

-HK$0.72(-6.22%)

Day’s Range― - ―

52-Week RangeHK$8.10 - HK$23.50

Previous CloseN/A

Volume9.24M

Average Volume (3M)5.64M

Market Cap

HK$5.03B

Enterprise ValueHK$5.86B

Total Cash (Recent Filing)N/A

Total Debt (Recent Filing)N/A

Price to Earnings (P/E)―

Beta1.33

Next Earnings

Mar 31, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.38

Shares Outstanding446,466,340

10 Day Avg. Volume2,639,970

30 Day Avg. Volume5,642,659

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)0.00

Price to Sales (P/S)0.00

P/FCF Ratio0.00

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

HK$24.16

Price Target Upside44.41% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering1

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Clinical Trial ProgressLAE102’s phase 1 clinical trial completion could trigger licensing interest from Eli Lilly and other global players.

Licensing OpportunitiesThere is a higher likelihood that Eli Lilly will license in Laekna’s LAE102 for muscle loss prevention, with Eli Lilly’s clinical trial disclosures suggesting LAE102 may be a stronger candidate for the indication.

Market Valuation UpsideThe valuation of obesity drug acquisitions suggests significant upside for Laekna, given its market cap and its potential to address the key weakness of obesity drugs.

Bears Say

Share Dilution ImpactLower TP by 9% to reflect share dilution post fundraising.

Laekna, Inc. News

Laekna, Inc. Partners with Qilu Pharma for Exclusive Licensing of LAE002 in China

Laekna, Inc. ( ($HK:2105) ) has shared an update. Laekna, Inc. has entered into an exclusive licensing agreement...

27d ago

2105

Laekna, Inc. Advances Breast Cancer Treatment with Promising Clinical Study

Laekna, Inc. (($HK:2105)) announced an update on their ongoing clinical study. Study Overview: Laekna, Inc. is conducting a...

1M ago

2105

Laekna, Inc. Advances Obesity Treatment with LAE102 Study

Laekna, Inc. (($HK:2105)) announced an update on their ongoing clinical study. Laekna, Inc. (HK:2105) is conducting a Phase...

1M ago

2105

Laekna, Inc. Reports Positive Phase I Results for Obesity Treatment

Laekna, Inc. ( ($HK:2105) ) has issued an announcement. Laekna, Inc. announced positive preliminary results from their Phase...

2M ago

2105

Laekna, Inc. Completes Successful Share Placement to Boost R&D

Laekna, Inc. ( ($HK:2105) ) has shared an update. Laekna, Inc. announced the successful completion of a placement...

3M ago

2105

Laekna, Inc. Advances Obesity Treatment with Promising Clinical Trial Results

The latest announcement is out from Laekna, Inc. ( ($HK:2105) ). Laekna, Inc. announced significant progress in its...

4M ago

2105

Laekna, Inc. Secures FDA Approval for New Metabolic Disease Therapy

Laekna, Inc. ( ($HK:2105) ) has issued an announcement. Laekna, Inc. has announced that it has received approval...

4M ago

2105

Laekna, Inc. Schedules Board Meeting to Review Interim Results

Laekna, Inc. ( ($HK:2105) ) has issued an announcement. Laekna, Inc. has announced a board meeting scheduled for...

4M ago

2105

Laekna, Inc. Advances LAE103 with FDA Application

Laekna, Inc. ( ($HK:2105) ) has issued an announcement. Laekna, Inc. has submitted an Investigational New Drug application...

5M ago

2105

Laekna, Inc. Unveils Promising Study Results at ADA 2025

The latest update is out from Laekna, Inc. ( ($HK:2105) ). Laekna, Inc. announced the presentation of clinical...

6M ago

2105

2105 FAQ

What was Laekna, Inc.’s price range in the past 12 months?

Laekna, Inc. lowest stock price was HK$8.10 and its highest was HK$23.50 in the past 12 months.

What is Laekna, Inc.’s market cap?

Laekna, Inc.’s market cap is HK$5.03B.

When is Laekna, Inc.’s upcoming earnings report date?

Laekna, Inc.’s upcoming earnings report date is Mar 31, 2026 which is in 113 days.

How were Laekna, Inc.’s earnings last quarter?

Laekna, Inc. released its earnings results on Aug 13, 2025. The company reported -HK$0.381 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.381.

Is Laekna, Inc. overvalued?

According to Wall Street analysts Laekna, Inc.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Laekna, Inc. pay dividends?

Laekna, Inc. does not currently pay dividends.

What is Laekna, Inc.’s EPS estimate?

Laekna, Inc.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Laekna, Inc. have?

Laekna, Inc. has 446,466,340 shares outstanding.

What happened to Laekna, Inc.’s price movement after its last earnings report?

Laekna, Inc. reported an EPS of -HK$0.381 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 5.371%.

Which hedge fund is a major shareholder of Laekna, Inc.?

Currently, no hedge funds are holding shares in HK:2105

Laekna, Inc. Stock Smart Score

Neutral

Analyst Consensus

Moderate Buy

Average Price Target:
HK$24.16 (44.41% Upside)

Technicals

Fundamentals

Return on Equity

-34.39%

Trailing 12-Months

Asset Growth

14.20%

Trailing 12-Months

Top Smart Score Stocks >

Laekna, Inc. (2105) Earnings & Revenues

Historic Earnings Reports

2105 Stock 12 Month Forecast

Average Price Target

HK$24.16

▲(44.41% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"3":"HK$3","14":"HK$14","25":"HK$25","8.5":"HK$8.5","19.5":"HK$19.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":24.16,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">HK$24.16</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":24.16,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">HK$24.16</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":24.16,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">HK$24.16</span>\n  </div></div>","useHTML":true}}],"tickPositions":[3,8.5,14,19.5,25],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Dec<br/>2024","6":"Mar<br/>2025","9":"Jun<br/>2025","12":"Sep<br/>2025","25":"Sep<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,15.87,16.507692307692306,17.145384615384614,17.783076923076923,18.42076923076923,19.058461538461536,19.696153846153845,20.333846153846153,20.97153846153846,21.60923076923077,22.246923076923075,22.884615384615387,23.52230769230769,{"y":24.16,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,15.87,16.507692307692306,17.145384615384614,17.783076923076923,18.42076923076923,19.058461538461536,19.696153846153845,20.333846153846153,20.97153846153846,21.60923076923077,22.246923076923075,22.884615384615387,23.52230769230769,{"y":24.16,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,15.87,16.507692307692306,17.145384615384614,17.783076923076923,18.42076923076923,19.058461538461536,19.696153846153845,20.333846153846153,20.97153846153846,21.60923076923077,22.246923076923075,22.884615384615387,23.52230769230769,{"y":24.16,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":4.9,"date":1725148800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":6.61,"date":1727740800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":9.13,"date":1730419200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":14.98,"date":1733011200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":9.37,"date":1735689600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":8.81,"date":1738368000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":12.52,"date":1740787200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":12.52,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.12,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.16,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.46,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.52,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.87,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >